Investegate |Thames Ventures VCT 2 plc Announcements | Thames Ventures VCT 2 plc: Publication of Healthcare Prospectus
Investegate announcements from Thames Ventures VCT 2 plc, Publication of Healthcare Prospectus
Stay updated with breaking news from Securities Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Thames Ventures VCT 2 plc, Publication of Healthcare Prospectus
Investegate announcements from Maven Inc &Grwth VCT, Publication of a Prospectus
Saint Herblain (France), September 30, 2022 – Valneva SE VALNVLA (the "Company"), a specialty vaccine company, announced today the pricing of 21,000,0
End of the stabilization operations with the partial exercise of the over-allotment option Final amount of the offer increased to 17.4 million euros following the partial exercise of the Over-Allotment
Launch of a Capital Increase With Shareholders' Preferential Subscription Rights for an Amount of Approximately EUR 50 Million Subscription ratio: 27 new shares for 4 preferential subscription